AbbVie (NYSE: ABBV) will announce its third-quarter 2024 financial results on Wednesday, October 30, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 ...

AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ...

The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...

Leerink Partners analyst David Risinger has maintained their neutral stance on ABBV stock, giving a Hold rating on September 13. David ...

North Chicago-based AbbVie filed the lawsuit in Chicago federal court Sept. 6, accusing Huaqing Liu, also a defendant in the case, of disclosing valuable trade secrets to BeiGene, which has ...

AbbVie on Friday said the application covers telisotuzumab vedotin, or teliso-V, in adults with previously treated, locally advanced or metastatic epidermal growth factor receptor wild type, ...

Such cells produce antibodies that fight infection. North Chicago-based AbbVie alleged that BeiGene, which has administrative offices in Basel, Beijing and Cambridge, Massachusetts, “enticed and ...

AbbVie (NYSE: ABBV) today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for accelerated approval of telisotuzumab vedotin (Teliso-V) in ...

AbbVie said tavapadon met the primary endpoint in the pivotal Phase 3 fixed-dose monotherapy trial, showing a statistically significant improvement in certain measures of the disease from baseline ...

Now, one of those drugs, Eli Lilly's Zepbound, is being studied for use as an anti-inflammatory treatment for psoriasis, a condition that North Chicago-based AbbVie treats with Humira and other ...

The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that a migraine medication commercial featuring Serena Williams is ...